MedTrace Logo

Inactivated Influenza Via Jet Injection

NCT02290691 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 985

Last updated 2017-11-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if the administration of flu vaccine using Needle-Free is equivalent to Needle and Syringe administration as measured by laboratory tests of immune response.

Conditions

  • Influenza, Human

Interventions

BIOLOGICAL

Influenza Vaccine

Influenza Vaccine

Sponsors & Collaborators

  • PharmaJet, Inc.

    lead INDUSTRY

Principal Investigators

  • William Gannon, MD · PharmaJet, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02290691 on ClinicalTrials.gov